Literature DB >> 27196511

ILC2s masquerade as ILC1s to drive chronic disease.

Gabrielle T Belz1.   

Abstract

Entities:  

Mesh:

Year:  2016        PMID: 27196511     DOI: 10.1038/ni.3467

Source DB:  PubMed          Journal:  Nat Immunol        ISSN: 1529-2908            Impact factor:   25.606


× No keyword cloud information.
  5 in total

1.  A T-bet gradient controls the fate and function of CCR6-RORγt+ innate lymphoid cells.

Authors:  Christoph S N Klose; Elina A Kiss; Vera Schwierzeck; Karolina Ebert; Thomas Hoyler; Yannick d'Hargues; Nathalie Göppert; Andrew L Croxford; Ari Waisman; Yakup Tanriver; Andreas Diefenbach
Journal:  Nature       Date:  2013-01-16       Impact factor: 49.962

2.  IL-1 is a critical regulator of group 2 innate lymphoid cell function and plasticity.

Authors:  Yoichiro Ohne; Jonathan S Silver; LuAnn Thompson-Snipes; Magalie A Collet; Jean Philippe Blanck; Brandi L Cantarel; Alan M Copenhaver; Alison A Humbles; Yong-Jun Liu
Journal:  Nat Immunol       Date:  2016-04-25       Impact factor: 25.606

3.  Inflammatory triggers associated with exacerbations of COPD orchestrate plasticity of group 2 innate lymphoid cells in the lungs.

Authors:  Jonathan S Silver; Jennifer Kearley; Alan M Copenhaver; Caroline Sanden; Michiko Mori; Li Yu; Gretchen Harms Pritchard; Aaron A Berlin; Christopher A Hunter; Russell Bowler; Jonas S Erjefalt; Roland Kolbeck; Alison A Humbles
Journal:  Nat Immunol       Date:  2016-04-25       Impact factor: 25.606

4.  IL-1β, IL-4 and IL-12 control the fate of group 2 innate lymphoid cells in human airway inflammation in the lungs.

Authors:  Suzanne M Bal; Jochem H Bernink; Maho Nagasawa; Jelle Groot; Medya M Shikhagaie; Kornel Golebski; Cornelis M van Drunen; Rene Lutter; Rene E Jonkers; Pleun Hombrink; Melanie Bruchard; Julien Villaudy; J Marius Munneke; Wytske Fokkens; Jonas S Erjefält; Hergen Spits; Xavier Romero Ros
Journal:  Nat Immunol       Date:  2016-04-25       Impact factor: 25.606

5.  The transcription factor T-bet is essential for the development of NKp46+ innate lymphocytes via the Notch pathway.

Authors:  Lucille C Rankin; Joanna R Groom; Michaël Chopin; Marco J Herold; Jennifer A Walker; Lisa A Mielke; Andrew N J McKenzie; Sebastian Carotta; Stephen L Nutt; Gabrielle T Belz
Journal:  Nat Immunol       Date:  2013-03-03       Impact factor: 25.606

  5 in total
  6 in total

1.  Differential Effect of Mucosal NKp44+ Innate Lymphoid Cells and Δγ Cells on Simian Immunodeficiency Virus Infection Outcome in Rhesus Macaques.

Authors:  Mohammad Arif Rahman; Eun-Ju Ko; Gospel Enyindah-Asonye; Sabrina Helmold Hait; Christopher Hogge; Ruth Hunegnaw; David J Venzon; Tanya Hoang; Marjorie Robert-Guroff
Journal:  J Immunol       Date:  2019-09-25       Impact factor: 5.422

2.  Mutations in JAK2 and Calreticulin genes are associated with specific alterations of the immune system in myelofibrosis.

Authors:  Marco Romano; Daria Sollazzo; Sara Trabanelli; Martina Barone; Nicola Polverelli; Margherita Perricone; Dorian Forte; Simona Luatti; Michele Cavo; Nicola Vianelli; Camilla Jandus; Francesca Palandri; Lucia Catani
Journal:  Oncoimmunology       Date:  2017-07-05       Impact factor: 8.110

Review 3.  Innate Lymphoid Cells in HIV/SIV Infections.

Authors:  Spandan V Shah; Cordelia Manickam; Daniel R Ram; R Keith Reeves
Journal:  Front Immunol       Date:  2017-12-13       Impact factor: 7.561

4.  Vaccination route can significantly alter the innate lymphoid cell subsets: a feedback between IL-13 and IFN-γ.

Authors:  Zheyi Li; Ronald J Jackson; Charani Ranasinghe
Journal:  NPJ Vaccines       Date:  2018-03-12       Impact factor: 7.344

5.  Eomes Expression Defines Group 1 Innate Lymphoid Cells During Metastasis in Human and Mouse.

Authors:  Riva Verma; Jun Zhi Er; Ren Wei Pu; Jameelah Sheik Mohamed; Ross A Soo; Harish Mithiran Muthiah; John Kit Chung Tam; Jeak Ling Ding
Journal:  Front Immunol       Date:  2020-06-17       Impact factor: 7.561

6.  Tissue-resident lymphocytes: sentinel of the transformed tissue.

Authors:  Saïda Dadi; Ming O Li
Journal:  J Immunother Cancer       Date:  2017-05-16       Impact factor: 13.751

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.